Why One Shilajit Study Does Not Prove a Health Claim

Why one study isn’t enough

The role of chance

In a small trial, a few participants responding unusually can shift the average. Statistical tests estimate how likely a result is to be due to chance, but a “significant” result in one small study can still fail to repeat. That is a normal feature of research, not a flaw in any particular study; see statistical significance and sample size.

What replication adds

When different researchers, with different participants and ideally different funders, find similar results, chance and design quirks become much less likely explanations. Replication is the step that turns an interesting result into reliable evidence. In our rating system, independent replication is one of the main factors that can move a topic up the scale; see evidence rating system.

Shilajit examples

Shilajit’s testosterone evidence comes mainly from one 90-day trial in healthy men aged 45 to 55.^[1] Its exercise evidence comes mainly from one trial in active men,^[2] and its bone evidence from one trial in postmenopausal women.^[3] Each is useful, but none has been widely replicated by independent groups with different preparations, which is why each topic is rated “Limited”; see evidence ratings.

Reviews and meta-analyses

Systematic reviews and meta-analyses combine several studies, which can give a clearer picture than any single trial. For tongkat ali, for example, a 2022 meta-analysis pooled five randomised trials on testosterone.^[4] Shilajit doesn’t yet have enough similar human trials for that kind of pooled analysis on most topics.

How UK rules reflect this

Health claims on foods and supplements in the UK must be authorised, which requires a substantial body of evidence rather than a single study.^[5] Shilajit has no authorised health claims, so products can’t legally claim, for example, that it boosts testosterone; see UK claims rules and testosterone claims.

How single studies get used in marketing

• “Clinically proven”Often based on one trial.
• “Studies show”Sometimes one study, sometimes animal studies.
• Borrowed evidenceA trial of one extract used to sell another product.

See “clinically proven” claims.

Single studies still matter

None of this makes single studies worthless. A well-designed trial is real evidence and a reason to investigate further. The point is proportion: one trial supports a cautious statement, not a confident claim.

Putting it into practice

When you see a benefit claim, ask how many human studies support it and whether they were independent. One study means “early evidence”; several consistent studies from different groups mean much more. Check our evidence ratings for each topic.

A comparison that shows replication at work

Tongkat ali offers a useful contrast. Several randomised trials on testosterone have been pooled in a meta-analysis, giving a larger evidence base than shilajit has on the same question.^[4] Even there, the effect appeared mainly in men with low testosterone, and much of the research was funded by one extract maker.^[6] Replication improves confidence; it doesn’t remove every question.

What would strengthen shilajit evidence

Larger trials, run by independent groups, using clearly described preparations and outcomes that matter to people, would do most to strengthen the evidence. Until then, each shilajit benefit remains a question worth investigating rather than a settled fact; see evidence gaps.

In short

One study opens a question; replication starts to answer it. Most shilajit benefits are still at the first stage, which is why careful language and realistic expectations matter. When a product calls a single trial “proof”, treat that as a sign of marketing rather than evidence.

What this means when you buy

When a product page leans on “a study shows”, check our rating for that topic before deciding. A Limited rating means there is some human evidence, but you should expect uncertainty about whether, and how much, shilajit will help. Treat it as a reason to try cautiously, with realistic expectations, rather than as a promise of results.

The bottom line

A single study, however interesting, can be affected by chance, its participants, preparation, design or funding. Replication builds confidence. Most shilajit benefits rest on one or two small trials, so treat them as early evidence, not proof.

Related reading